Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
1090.9%
Followers on X. Updated Oct 9, 2026
Loading...

Actuate Therapeutics X Follower Count

Actuate Therapeutics has 109 followers on X (formerly Twitter), up 12.4% over the past three months. Rising follower counts on X point to growing public interest and brand visibility.

With 109 followers, Actuate Therapeutics has a smaller X following than industry peers like Amgen (118,624) and Gilead Sciences (72,279).

How Actuate Therapeutics’s X Growth Feeds the ACTU AI Score

X follower trends are particularly relevant for companies with strong direct-to-consumer brands or high-profile leadership. A follower count is not a stock price on its own, but for consumer-facing companies a sustained shift in following can reflect changing brand momentum. AltIndex feeds Actuate Therapeutics’s X following into the ACTU AI Score as one of 25+ alternative data signals, weighed against hiring, web traffic, sentiment, and fundamentals.

For Actuate Therapeutics’s reach on other platforms, see Actuate Therapeutics Instagram followers, TikTok followers, YouTube subscribers, and Facebook followers.

For real-time conversation volume, see ACTU X mentions. For other demand signals, see web traffic, app downloads, and Google Trends.

Actuate Therapeutics X (Twitter) Followers: Frequently Asked Questions

Actuate Therapeutics has 109 followers (109) on X (formerly Twitter), based on AltIndex’s tracking of the company’s official X account.

Actuate Therapeutics's X following is growing, up 12.4% over the past three months. View the trend chart above for the full history.

X follower trends are most telling for companies with strong direct-to-consumer brands or high-profile leadership. No single data point predicts a stock on its own, but a sustained change in Actuate Therapeutics's following can reflect shifting public interest. That is why AltIndex combines Actuate Therapeutics's X following with web traffic, hiring, sentiment, and 20+ other signals in its AI Score rather than reading any one signal in isolation.

Actuate Therapeutics underperforms its industry peers when it comes to X Followers, ranking dead last.

With fewer than 1,000 followers, Actuate Therapeutics' X account is in its growth phase, focusing on building its audience. This suggests a niche but potentially dedicated following, important for targeted engagement.

Sign up and get more insights on Actuate Therapeutics.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.